
The WHO reported that South-East Asia is struggling to meet 2030 TB elimination targets, with the region accounting for 3.68 million new cases and 433,000 deaths in 2024.
Regional TB funding remains critically low, with only $900 million available in 2024 against an estimated requirement of $3 billion to effectively combat the disease.
While India recorded a 21% decline in TB incidence between 2015 and 2024, antimicrobial resistance persists, with 150,000 people developing multidrug and rifampicin-resistant tuberculosis.